Science Based Targets initiative (SBTi) validates EUROAPI's near-term climate targets

Core Insights - EUROAPI's near-term science-based emission reduction targets have been approved by the Science Based Targets initiative (SBTi), aligning the company with the Paris Agreement to limit global warming to 1.5°C above pre-industrial levels [1] - The company commits to a 42% reduction in absolute Scope 1 and 2 greenhouse gas emissions by 2030 from a 2022 base year, and a 25% reduction in absolute Scope 3 GHG emissions in the same timeframe [1][5] Environmental Commitments - The CEO of EUROAPI emphasized the importance of sustainable industrial operations and improving the environmental footprint as a key ESG priority [2] - The company has achieved measurable improvements in environmental indicators, including a 28% reduction in waste, a 14% reduction in solvent use, and a 12% reduction in energy consumption between 2022 and 2024 [2] - EUROAPI eliminated nearly 180,000 tons of CO2 equivalent in two years, equivalent to the annual GHG emissions of a city with around 20,000 inhabitants [2] Product and Market Position - EUROAPI focuses on reinventing active ingredient solutions to meet global customer and patient needs, with approximately 200 products in its portfolio [3] - The company operates five manufacturing sites in Europe and supplies customers in over 80 countries, ensuring high-quality API manufacturing [4]